| # | Drug | Count |
|---|---|---|
| 0 | PEGFILGRASTIM | 75 |
| 1 | CYCLOPHOSPHAMIDE | 37 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 37 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 37 |
| 4 | FILGRASTIM | 32 |
| 5 | EPIRUBICIN HYDROCHLORIDE | 29 |
| 6 | DOXORUBICIN | 20 |
| 7 | DOXORUBICIN HYDROCHLORIDE | 19 |
| 8 | DOCETAXEL | 17 |
| 9 | DOCETAXEL ANHYDROUS | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PURIFIED WATER | 1 | 0.0204 |
| 1 | PEGFILGRASTIM | 75 | 0.0063 |
| 2 | EPIRUBICIN HYDROCHLORIDE | 29 | 0.0045 |
| 3 | CABAZITAXEL | 11 | 0.0031 |
| 4 | GLYCERINE | 1 | 0.0031 |
| 5 | APREPITANT | 11 | 0.0015 |
| 6 | CASPOFUNGIN ACETATE | 2 | 0.0013 |
| 7 | DEXRAZOXANE FOR INJECTION | 1 | 0.0011 |
| 8 | RAMUCIRUMAB | 6 | 0.0009 |
| 9 | PALONOSETRON HYDROCHLORIDE | 5 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 11 | 0.0013 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 6 | 0.0009 |
| 2 | Leukocyte Growth Factor [EPC] | 85 | 0.0006 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Topoisomerase Inhibitor [EPC] | 17 | 0.0002 |
| 5 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 6 | Alkylating Drug [EPC] | 43 | 0.0002 |
| 7 | Penem Antibacterial [EPC] | 5 | 0.0001 |
| 8 | Microtubule Inhibitor [EPC] | 24 | 0.0001 |
| 9 | BCL-2 Inhibitor [EPC] | 8 | 0.0001 |